
Advamab 400 Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Bevacizumab (400mg)
Overview Advamab 400 Injection
Advamab 400 Injection, an anti-cancer agent, treats cancers of the colon, rectum, non-small cell lung, kidney, brain, ovary, and cervix. Its mechanism involves inhibiting tumor angiogenesis, thus hindering tumor growth. Highly effective, it's often a first-line treatment when combined with other cancer therapies. Administered intravenously via infusion (either directly into a vein or through a subcutaneous port), dosage and treatment duration are determined by your physician, who will also monitor for infusion reactions like hypertension and respiratory distress. Continued use depends on disease control and manageable side effects; discontinuation is decided by your doctor. Regular monitoring of blood pressure and urinary protein levels may be recommended. Common side effects include rectal hemorrhage, altered taste perception, and cephalalgia. Pre-surgical notification of Advamab 400 Injection use is crucial due to its potential to impair wound healing and increase bleeding risk; report any unusual bleeding immediately. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician. Inform your healthcare provider of all other medications you are taking, as drug interactions are possible.
Uses of Advamab 400 Injection
Colorectal cancer, ovarian malignancy, cervical carcinoma, renal cell carcinoma, brain neoplasm, and non-small cell lung carcinoma.
Major Benefits of Advamab 400 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Advamab 400 Injection:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Advamab 400 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Advamab 400 Injection works:
Advamab 400 Injection is an anti-angiogenesis therapy. Its mechanism of action involves inhibiting vascular endothelial growth factor (VEGF), a protein crucial for blood vessel development. This action deprives cancerous tumors of the oxygen and nutrients supplied by newly formed blood vessels.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Advamab 400 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Advamab 400 Injection might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Limited evidence indicates that Advamab 400 Injection may pose a risk to breastfeeding infants. The drug's potential transfer into breast milk and consequent harm to the baby warrants caution.
DrivingUNSAFE
Advamab 400 Injection may induce adverse reactions that could compromise driving ability. Reported side effects include drowsiness and loss of consciousness, potentially affecting safe driving.
KidneySAFE IF PRESCRIBED
Advamab 400 Injection appears safe for individuals with kidney impairment. Preliminary evidence indicates dose modification may be unnecessary in this population. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Advamab 400 Injection appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification of Advamab 400 Injection may be unnecessary in this population; however, physician consultation is recommended.
What if you forget to take Advamab 400 Injection :
Omit a dose of Advamab 400 Injection? Seek your physician's advice.
Facts to Know About Advamab 400 Injection
| Label | Value |
|---|---|
| Type of Compound | Single-clone antibody |
| Addictive | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Agent that blocks vascular endothelial growth factor (VEGF) |
